NCT03739957

Brief Summary

A tailored management of COPD patients would obviously allow to reduce costs for hospitalizations and improve quality of life. This management could benefit of the Information and Comunication Technology support, which can offer the possibility of telemonitoring patients without the need of repeated hospital visits and improving the efficacy of healthcare services. Moreover, the high frequency of exacerbations and their often atypical clinical presentation in the aged patient make particularly desirable the availability of a telemonitoring system which could guarantee continuous control and early intervention in case of necessity. The aim of the present study is to test an innovative telemonitoring system in patients with COPD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 14, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

February 20, 2020

Status Verified

February 1, 2020

Enrollment Period

3 years

First QC Date

November 5, 2018

Last Update Submit

February 18, 2020

Conditions

Keywords

COPDTelemonitoring systems

Outcome Measures

Primary Outcomes (1)

  • Number of participants needing ER or hospital admission for bronchial exacerbation

    The cause of ER or hospital admission will be referred to bronchial exacerbation if any change occurred in respiratory health that requires a change in drug therapy.

    One year

Study Arms (1)

BPCO Media Kit

EXPERIMENTAL

The kit is composed of a Bluetooth pulse oximeter and an APP for Android system downloadable from Google Play and installed on the Android smartphone of the patient from version 4.1 on.

Device: BPCO Media Kit

Interventions

Telemonitoring system for patients with COPD

BPCO Media Kit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with COPD with two or more exacerbations every year or at least one leading to hospitalization.

You may not qualify if:

  • long-term oxygen therapy
  • cognitive impairment
  • a life expectancy limited to one year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

ASSL Cagliari - Pneumologia Territoriale di Cagliari Area Vasta

Cagliari, Sardinia, Italy

RECRUITING

ASSL Lanusei - Distretto di Tortolì

Lanusei, Sardinia, Italy

RECRUITING

ASSL Nuoro - Distretto di Nuoro

Nuoro, Sardinia, Italy

RECRUITING

Related Publications (1)

  • Merone M, Pedone C, Capasso G, Incalzi RA, Soda P. A Decision Support System for Tele-Monitoring COPD-Related Worrisome Events. IEEE J Biomed Health Inform. 2017 Mar;21(2):296-302. doi: 10.1109/JBHI.2017.2654682. Epub 2017 Jan 17.

    PMID: 28103562BACKGROUND

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Raffaele Antonelli Incalzi, MD

    Campus BioMedico

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Antonio De Vincentis, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2018

First Posted

November 14, 2018

Study Start

January 1, 2019

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

February 20, 2020

Record last verified: 2020-02

Locations